Aminosyn and Aminosyn II products infused with dextrose by peripheral vein infusion are indicated as a source of nitrogen in the nutritional support of patients with adequate stores of body fat, in whom, for short periods of time, oral nutrition cannot be tolerated, is undesirable or is inadequate.
When administered with concentrated dextrose solution with or without fat emulsions they are also indicated for central vein infusion to prevent or reverse negative nitrogen balance in patients where: (a) the alimentary tract by the oral, gastrostomy or jejunostomy route cannot or should not be used; (b) gastrointestinal absorption of protein is impaired; (c) metabolic requirements for protein are substantially increased as with extensive burns and (d) morbidity and mortality may be reduced by replacing amino acids lost from tissue breakdown, thereby preserving tissue reserves, as in acute renal failure.
- This product contains aluminum, which may be toxic
- Contraindicated in patients with hepatic coma or metabolic disorders involving impaired nitrogen utilization
- Flexible containers should not be used in series connections
- Additives may be incomplete. Consult with pharmacist, if available. When compounding admixtures use aseptic technique. Mix thoroughly. Because of the potential for life-threatening events, caution should be taken to ensure that precipitates have not formed in any parenteral mixture.
Pharmacy bulk packages are not for direct infusion. Sterile Water for Injection and 50% and 70% Dextrose for Injection, USP Pharmacy Bulk Package are for use only with automated compounding devices.